Its molecular pathology revealed evidence of mutations in IDH1 and TP53 (Figure 4d–e), no evidence of chromosome 1p/19q codeletion, and a KI67 labeling index of 4%, consistent with a recurrent CNS WHO grade 2 IDH-mutant astrocytoma. This evidence concerns the gene TP53 and astrocytoma (excluding glioblastoma).